glp-1 fda approval Lilly is now pharma's top revenue company. It just got for an oral GLP-1, but Wall Street isn't celebrating GLP-1 RAs gain popularity as

Key effects of GLP-1 medications Encourage insulin release when blood sugar rises Slow stomach emptying to improve digestion and increase fullness Reduce appetite Lower post-meal glucose spikes Support sustainable weight loss efforts Because many GLP-1 drugs come with high monthly costs, people often use price comparison resources to get a sense of price ranges before deciding which option to pursue

10 , 17 If the dose is fixed at 2.4 mg but the dosing interval is increased to 14 days (q2wk), the model predicts a steadystate body weight reduction of 12%

4, 2025, pp

(2021) Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial